Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. 1974

J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002330 Carmustine A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) BCNU,1,3-Bis(2-Chloroethyl)-1-Nitrosourea,BiCNU,FIVB,N,N'-Bis(2-Chloroethyl)-N-Nitrosourea,Nitrumon
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
October 1973, Cancer,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
January 1977, Cancer,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
January 1977, Cancer,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
November 1971, Cancer,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
February 1973, Cancer chemotherapy reports,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
January 1974, Cancer research,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
October 1973, Cancer,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
April 1971, Cancer chemotherapy reports,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
February 1976, Annals of internal medicine,
J U Gutterman, and G Mavligit, and J A Gottlieb, and M A Burgess, and C E McBride, and L Einhorn, and E J Freireich, and E M Hersh
January 1970, Journal of surgical oncology,
Copied contents to your clipboard!